ABBV-8E12, A HUMANIZED ANTI-TAU MONOCLONAL ANTIBODY, FOR TREATING EARLY ALZHEIMER’S DISEASE: UPDATED DESIGN AND BASELINE CHARACTERISTICS OF A PHASE 2 STUDY
Florian, Hana, Arnold, Steven E., Bateman, Randall, Braunstein, Joel B., Budur, Kumar, Kerwin, Diana R., Soares, Holly, Wang, Deli, Holtzman, David M.Volume:
15
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2019.06.075
Date:
July, 2019
File:
PDF, 335 KB
english, 2019